- Home
- NRXP vs RDI Comparison
NRXP vs RDI Comparison
Compare NRXP & RDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXP
- RDI
- Stock Information
- Founded
- NRXP 2015
- RDI 1937
- Country
- NRXP United States
- RDI United States
- Employees
- NRXP N/A
- RDI N/A
- Industry
- NRXP Biotechnology: Pharmaceutical Preparations
- RDI Movies/Entertainment
- Sector
- NRXP Health Care
- RDI Consumer Discretionary
- Exchange
- NRXP Nasdaq
- RDI Nasdaq
- Market Cap
- NRXP 32.6M
- RDI 30.6M
- IPO Year
- NRXP N/A
- RDI N/A
- Fundamental
- Price
- NRXP $3.34
- RDI $1.27
- Analyst Decision
- NRXP Strong Buy
- RDI Hold
- Analyst Count
- NRXP 4
- RDI 1
- Target Price
- NRXP $28.50
- RDI $2.40
- AVG Volume (30 Days)
- NRXP 240.0K
- RDI 31.9K
- Earning Date
- NRXP 08-13-2025
- RDI 08-13-2025
- Dividend Yield
- NRXP N/A
- RDI N/A
- EPS Growth
- NRXP N/A
- RDI N/A
- EPS
- NRXP N/A
- RDI N/A
- Revenue
- NRXP N/A
- RDI $205,644,000.00
- Revenue This Year
- NRXP N/A
- RDI $7.47
- Revenue Next Year
- NRXP N/A
- RDI $13.22
- P/E Ratio
- NRXP N/A
- RDI N/A
- Revenue Growth
- NRXP N/A
- RDI N/A
- 52 Week Low
- NRXP $1.10
- RDI $1.17
- 52 Week High
- NRXP $6.01
- RDI $1.89
- Technical
- Relative Strength Index (RSI)
- NRXP 56.68
- RDI 43.09
- Support Level
- NRXP $2.90
- RDI $1.21
- Resistance Level
- NRXP $3.53
- RDI $1.31
- Average True Range (ATR)
- NRXP 0.19
- RDI 0.06
- MACD
- NRXP -0.03
- RDI -0.01
- Stochastic Oscillator
- NRXP 69.84
- RDI 29.95
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About RDI Reading International Inc
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.